Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Sidera Bio has raised $109.0M in total funding. The most recent round was Series A. The last funding was announced in December 2025.
Sidera Bio's investors include RA Capital Management, Catalio Capital Management, Novo Holdings, Forbion Capital Partners, Gilde Healthcare.
Sidera Bio is headquartered in Copenhagen, Denmark.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Sidera Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sidera Bio — Funding & Investors." VCBacked, December 9, 2025, https://www.vcbacked.co/company/sidera-bio. Accessed July 19, 2026.
VCBacked. (2025). Sidera Bio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/sidera-bio
{{cite web |title=Sidera Bio — Funding & Investors |url=https://www.vcbacked.co/company/sidera-bio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated